Delivery Order SPE2DE24D0013-SPE2D625F2QTN
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a $8,640 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 9, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, is for diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection, with performance completion targeted for September 16, 2025. The contract contains no set-aside designation and represents a...
- The U.S. Department of Defense's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on September 10, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by September 17, 2025, and carries no set-aside designation. The contract nomenclature indicates the order involves diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial...
- The U.S. Defense Department's Medical Supply Chain awarded a $204,000 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 15, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by September 22, 2025, and carries no set-aside designation. This award represents a continuation of the department's partnership with Cepheid to procure diagnostic testing solutions, specifically for...
- The U.S. Defense Department's Medical Supply Chain awarded Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, a firm fixed-price delivery order valued at $20,400 on August 11, 2025, with an ultimate completion date of August 18, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV)—infectious diseases commonly detected through Cepheid's GeneXpert molecular...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, on September 10, 2025. The delivery order, designated XPCOV2/FLU/RSV-10 with an ultimate completion date of September 17, 2025, carries no set-aside designation. This award represents a procurement of diagnostic testing solutions, specifically reagents and test kits for detecting COVID-19, influenza, and...
- The U.S. Defense Department's Medical Supply Chain awarded a $6,800 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, for XPCOV2/FLU/RSV-10 testing solutions. This delivery order, issued on July 18, 2025, with an ultimate completion date of July 25, 2025, carries no set-aside designation and represents procurement of diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The...
- The U.S. Defense Department's Medical Supply Chain awarded a $2,960 firm fixed-price delivery order to Cepheid Inc. on September 17, 2025, with an ultimate completion date of September 24, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Cepheid, a Sunnyvale, California-based manufacturer specializing in molecular diagnostic systems and test kits for infectious diseases,...
- The U.S. Defense Department's Medical Supply Chain awarded a $7,907.58 firm fixed-price delivery order to Cepheid Inc. on July 15, 2025, with an ultimate completion date of July 22, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, involves molecular diagnostic testing solutions, specifically reagents and assays for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). The work will be performed in Sunnyvale, California, and no small business set-aside designation was...
- The Defense Department's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, on September 5, 2025, with completion targeted for September 12, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract contains no set-aside designation and represents a...
- The U.S. Department of Defense, through its Medical Supply Chain division, awarded a $20,400 firm fixed-price delivery order to Cepheid Inc. on July 10, 2025, with an ultimate completion date of July 17, 2025. The contract, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Cepheid, a Sunnyvale, California-based manufacturer specializing in advanced diagnostic systems, will perform the work at its...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F2QTNDelivery Order
The U.S. Defense Department's Medical Supply Chain awarded a $7,480 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, on September 5, 2025, with completion targeted for September 19, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries no set-aside designation and represents a continuation of Cepheid's established relationship as a supplier of molecular diagnostic testing solutions to federal healthcare and defense agencies. This delivery order likely derives from one of Cepheid's existing Indefinite Delivery Vehicle contracts, such as the VA Veterans Integrated Service Network 21 IDV valued at $2.5 million, which specifically covers PCR testing for laboratory microbiology including COVID-19, influenza, and RSV diagnostics. Cepheid's federal contract portfolio demonstrates consistent demand for its GeneXpert diagnostic systems, reagents, and test kits across multiple federal agencies including the Department of Veterans Affairs, Defense Logistics Agency, and Defense Health Agency. The firm fixed-price structure and product focus align with Cepheid's core competency in providing rapid, point-of-care molecular diagnostic capabilities to federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 9/5/25 |